Valuation: Incyte Corporation

Market Cap 24.77B 21.46B 20.25B 18.37B 34.47B 2,374B 34.72B 242B 93.21B 1,204B 93.02B 90.97B 3,829B P/E 2026 *
54.5x
P/E 2027 * 16.9x
Enterprise Value 20.54B 17.8B 16.79B 15.24B 28.58B 1,968B 28.79B 201B 77.29B 999B 77.14B 75.44B 3,175B EV / Sales 2026 *
3.46x
EV / Sales 2027 * 3x
Free-Float
98.16%
Yield 2026 *
-
Yield 2027 * -
1 day-1.39%
1 week-3.60%
Current month-0.84%
1 month+1.69%
3 months+12.59%
6 months+32.04%
Current year+23.71%
1 week 121.28
Extreme 121.28
127.72
1 month 119.64
Extreme 119.64
130.8
Current year 89.25
Extreme 89.25
132.6
1 year 81.09
Extreme 81.09
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 26/06/2025
Director of Finance/CFO 57 04/05/2026
President 62 05/06/2023
Director TitleAgeSince
Chairman 59 26/06/2025
Director/Board Member 72 20/01/2015
Director/Board Member 64 20/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
25/8/26 Tax

EVP, Human Resources

-504 0.0002%
19/8/26 Sell

Chairperson

-10,801 0.0053%
12/8/26 Sell

Chairperson

-10,803 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%-3.60%+47.04%+92.49% 24.77B
-1.27%-4.11%+41.74%-4.64% 79.26B
-2.91%+0.78%+523.95%+30.03% 58.56B
+1.57%-0.31%-14.78%-34.90% 58.62B
+0.35%-3.14%-11.03%+26.34% 48.75B
-1.05%+0.68%+1.36%+147.39% 46.32B
-1.00%-1.57%+50.05%-15.20% 32.12B
-1.91%-5.19%-0.63%+142.35% 21.5B
-1.78%-3.24%+61.98%+97.23% 15.97B
-0.70%-3.29%+41.34%+144.36% 14.15B
Average -1.10%-1.88%+74.10%+62.55% 40B
Weighted average by Cap. -0.98%-1.71%+92.46%+39.78%

Financials

2026 *2027 *
Net sales 5.94B 5.15B 4.86B 4.41B 8.27B 570B 8.33B 58.03B 22.36B 289B 22.32B 21.83B 918B 6.27B 5.43B 5.12B 4.65B 8.72B 600B 8.78B 61.18B 23.58B 305B 23.53B 23.01B 968B
Net income 466M 404M 381M 346M 648M 44.65B 653M 4.55B 1.75B 22.65B 1.75B 1.71B 72.01B 1.5B 1.3B 1.22B 1.11B 2.08B 143B 2.1B 14.61B 5.63B 72.73B 5.62B 5.49B 231B
Net Debt -4.23B -3.67B -3.46B -3.14B -5.89B -405B -5.93B -41.31B -15.92B -206B -15.89B -15.54B -654B -5.99B -5.19B -4.9B -4.44B -8.34B -574B -8.4B -58.51B -22.54B -291B -22.5B -22.01B -926B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
15/09/26 USD 122.19 +0.59% 1,455,967
11/09/26 USD 121.47 -1.47% 1,425,198
10/09/26 USD 123.28 -2.17% 1,462,890
09/09/26 USD 126.01 +1.29% 1,301,228
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
122.19USD
Average target price
127.74USD
Spread / Average Target
+4.54%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!